Additional file 1: of A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies

Giacomini, Caterina; Koo, Chuay-Yeng; Yankova, Natalia; Tavares, Ignatius; Wray, Selina; Noble, Wendy; Hanger, Diane; Morris, Jonathan

doi:10.6084/m9.figshare.6225845.v1

40478_2018_539_MOESM1_ESM.docx (16.31 kB)

Additional file 1: of A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies

journal contribution

posted on 2018-05-07, 05:00 authored by Caterina Giacomini, Chuay-Yeng Koo, Natalia Yankova, Ignatius Tavares, Selina Wray, Wendy Noble, Diane Hanger, Jonathan Morris

Table S1. Characteristics of the subjects whose brain tissues were used in this study. PMD refers to post-mortem delay in hours before samples were processed. (DOCX 16 kb)

Funding

Alzheimerâs Research UK

History

Usage metrics

Keywords

Alzheimer Tauopathy Dementia TAOK Tau Phosphorylation Kinase

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1: of A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies

Funding

Alzheimerâs Research UK

History

Usage metrics

Categories

Keywords

Licence

Exports

Alzheimerâs Research UK